Serum level changes of inflammatory cytokines in patients with moderate to severe acne vulgaris treated with dual-wavelength laser

Williams, 2012, Acne vulgaris [published correction appears in Lancet, Lancet, 379, 361, 10.1016/S0140-6736(11)60321-8 Tan, 2008, Prevalence and severity of facial and truncal acne in a referral cohort, J Drugs Dermatol JDD, 7, 551 Younis, 2015, The interleukin-6 and interleukin-1A gene promoter polymorphism is associated with the pathogenesis of acne vulgaris, Arch Dermatol Res, 307, 365, 10.1007/s00403-014-1519-x Karadag, 2012, Immunoregulatory effects of isotretinoin in patients with acne, Br J Dermatol, 167, 433, 10.1111/j.1365-2133.2012.10949.x Dréno, 2017, What is new in the pathophysiology of acne, an overview, J Eur Acad Dermatol Venereol, 31, 8, 10.1111/jdv.14374 Contassot, 2014, New insights into acne pathogenesis: Propionibacterium acnes activates the inflammasome, J Invest Dermatol, 134, 310, 10.1038/jid.2013.505 Zouboulis, 2014, Acne is an inflammatory disease and alterations of sebum composition initiate acne lesions, J Eur Acad Dermatol Venereol, 28, 527, 10.1111/jdv.12298 Jugeau, 2005, Induction of toll-like receptors by Propionibacterium acnes, Br J Dermatol, 153, 1105, 10.1111/j.1365-2133.2005.06933.x Kim, 2005, Review of the innate immune response in acne vulgaris: activation of Toll-like receptor 2 in acne triggers inflammatory cytokine responses, Dermatology, 211, 193, 10.1159/000087011 Guy, 1998, Modelling the infundibulum in acne, Dermatology, 196, 32, 10.1159/000017862 Zhou, 2013, Palmitic acid induces production of proinflammatory cytokines interleukin-6, interleukin-1β, and tumor necrosis factor-α via a NF-κB-dependent mechanism in HaCaT keratinocytes [published correction appears in Mediators Inflamm. 2014;2014:513027, Mediat Inflamm, 2013 Sardana, 2017, Propionibacterium acnes and the Th1/Th17 axis, implications in acne pathogenesis and treatment, Indian J Dermatol, 62, 392, 10.4103/ijd.IJD_483_16 Abd El All, 2007, Immunohistochemical expression of interleukin 8 in skin biopsies from patients with inflammatory acne vulgaris, Diagn Pathol, 2, 4, 10.1186/1746-1596-2-4 McInturff, 2005, The role of toll-like receptors in the pathogenesis and treatment of dermatological disease, J Invest Dermatol, 125, 1, 10.1111/j.0022-202X.2004.23459.x Kistowska, 2015, Propionibacterium acnes promotes Th17 and Th17/Th1 responses in acne patients, J Invest Dermatol, 135, 110, 10.1038/jid.2014.290 Wolk, 2011, Deficiency of IL-22 contributes to a chronic inflammatory disease: pathogenetic mechanisms in acne inversa, J Immunol, 186, 1228, 10.4049/jimmunol.0903907 Agak, 2014, Propionibacterium acnes induces an IL-17 response in acne vulgaris that is regulated by vitamin A and vitamin D, J Invest Dermatol, 134, 366, 10.1038/jid.2013.334 Kelhälä, 2014, IL-17/Th17 pathway is activated in acne lesions, PLoS One, 9, 10.1371/journal.pone.0105238 Firinu, 2016, SAPHO syndrome: current developments and approaches to clinical treatment, Curr Rheumatol Rep, 18, 35, 10.1007/s11926-016-0583-y Webster, 1980, Polymorphonuclear leukocyte lysosomal release in response to Propionibacterium acnes in vitro and its enhancement by sera from inflammatory acne patients, J Invest Dermatol, 74, 398, 10.1111/1523-1747.ep12544494 Jabbari, 2011, Role of the immune system and immunological circuits in psoriasis, G Ital Dermatol Venereol, 146, 17 da Rocha, 2012, Increased serum interleukin 22 in patients with rheumatoid arthritis and correlation with disease activity, J Rheumatol, 39, 1320, 10.3899/jrheum.111027 Dudakov, 2015, Interleukin-22: immunobiology and pathology, Annu Rev Immunol, 33, 747, 10.1146/annurev-immunol-032414-112123 Liang, 2006, Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides, J Exp Med, 203, 2271, 10.1084/jem.20061308 Wiznia, 2017, Laser treatments of active acne, Laser Med Sci, 32, 1647, 10.1007/s10103-017-2294-7 Jung, 2009, Comparison of a pulsed dye laser and a combined 585/1,064-nm laser in the treatment of acne vulgaris, Dermatol Surg, 35, 1181, 10.1111/j.1524-4725.2008.34427.x Orringer, 2005, Dermal matrix remodeling after nonablative laser therapy, J Am Acad Dermatol, 53, 775, 10.1016/j.jaad.2005.07.052 Orringer, 2007, A randomized, controlled, split-face clinical trial of 1320-nm Nd:YAG laser therapy in the treatment of acne vulgaris, J Am Acad Dermatol, 56, 432, 10.1016/j.jaad.2006.10.978 Darné, 2011, Evaluation of the clinical efficacy of the 1,450 nm laser in acne vulgaris: a randomized split-face, investigator-blinded clinical trial, Br J Dermatol, 165, 1256, 10.1111/j.1365-2133.2011.10614.x Mohamed, 2021, 577-nm high-power optically pumped semiconductor laser is safe and effective in the treatment of inflammatory acne: a prospective, single-center, split-face comparative study, Eur J Med Res, 26, 103, 10.1186/s40001-021-00573-z Pillsbury, 1956 Askari, 2017, Association between acne and serum pro-inflammatory cytokines (IL-1α, IL-1β, IL-1Ra, IL-6, IL-8, IL-12 and RANTES) in mustard gas-exposed patients: sardasht-Iran cohort study, Arch Iran Med, 20, 86 Beylot, 2014, Propionibacterium acnes: an update on its role in the pathogenesis of acne, J Eur Acad Dermatol Venereol, 28, 271, 10.1111/jdv.12224 Jarrousse, 2007, Modulation of integrins and filaggrin expression by Propionibacterium acnes extracts on keratinocytes, Arch Dermatol Res, 299, 441, 10.1007/s00403-007-0774-5 Weber, 2019, Hop extract acts as an antioxidant with antimicrobial effects against Propionibacterium acnes and Staphylococcus aureus, Molecules, 24, 223, 10.3390/molecules24020223 Bailey, 2007, Chemokine expression is associated with the accumulation of tumour associated macrophages (TAMs) and progression in human colorectal cancer, Clin Exp Metastasis, 24, 121, 10.1007/s10585-007-9060-3 Fukaya, 2018, Pivotal role of IL-22 binding protein in the epithelial autoregulation of interleukin-22 signaling in the control of skin inflammation, Front Immunol, 9, 1418, 10.3389/fimmu.2018.01418 Wolk, 2009, IL-22 and IL-20 are key mediators of the epidermal alterations in psoriasis while IL-17 and IFN-gamma are not, J Mol Med (Berl), 87, 523, 10.1007/s00109-009-0457-0 Guo, 2018, Exosomes from heat-stressed tumour cells inhibit tumour growth by converting regulatory T cells to Th17 cells via IL-6, Immunology, 154, 132, 10.1111/imm.12874 Ankathatti Munegowda, 2011, Th17 and Th17-stimulated CD8⁺ T cells play a distinct role in Th17-induced preventive and therapeutic antitumor immunity, Cancer Immunol Immunother, 60, 1473, 10.1007/s00262-011-1054-y Zhang, 2011, Th22 in inflammatory and autoimmune disease: prospects for therapeutic intervention, Mol Cell Biochem, 353, 41, 10.1007/s11010-011-0772-y Sonnenberg, 2011, Border patrol: regulation of immunity, inflammation and tissue homeostasis at barrier surfaces by IL-22, Nat Immunol, 12, 383, 10.1038/ni.2025 Choi, 2010, Intense pulsed light vs. pulsed-dye laser in the treatment of facial acne: a randomized split-face trial, J Eur Acad Dermatol Venereol, 24, 773, 10.1111/j.1468-3083.2009.03525.x Erceg, 2006, Efficacy of the pulsed dye laser in the treatment of localized recalcitrant plaque psoriasis: a comparative study, Br J Dermatol, 155, 110, 10.1111/j.1365-2133.2006.07141.x Díez, 2011, Histopathology and immunohistochemistry of cutaneous lupus erythematosus after pulsed dye laser treatment, Dermatol Surg, 37, 971, 10.1111/j.1524-4725.2011.02041.x Fikrle, 2011, Granuloma Faciale treated with 595-nm pulsed dye laser, Dermatol Surg, 37, 102, 10.1111/j.1524-4725.2010.01823.x Roos, 2009, Successful treatment of cutaneous sarcoidosis lesions with the flashlamp pumped pulsed dye laser: a case report, Dermatol Surg, 35, 1139, 10.1111/j.1524-4725.2009.01202.x